{
  "meta": {
    "title": "Secondary_Amenorrhoea",
    "url": "https://brainandscalpel.vercel.app/secondary-amenorrhoea-284973f2.html",
    "scrapedAt": "2025-11-29T18:26:29.044Z"
  },
  "questions": [
    {
      "id": 12097,
      "choices": [
        {
          "id": 48352,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B, C, D, E</span></span></p>"
        },
        {
          "id": 48353,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B, C, D</span></span></p>"
        },
        {
          "id": 48354,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B</span></span></p>"
        },
        {
          "id": 48355,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A,B,D</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year female presents to OPD with secondary amenorrhea. She does not bleed on the progesterone challenge or even after giving her a course of combined estrogen and progesterone pills. Asherman syndrome is suspected. This can result from. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Curettage</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tuberculosis </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine artery embolization</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cesareans section</span></span></li>\r\n\t<li><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical biopsy</span></span></li>\r\n</ol>",
      "unique_key": "Q7339584",
      "question_audio": null,
      "question_video": null,
      "map_id": 18811,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. A, B, C, D</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option :</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Curettage</span></strong>: Asherman syndrome is often a result of trauma to the uterine lining, most commonly due to aggressive curettage, especially postpartum or post-abortion curettage.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tuberculosis</span></strong>: Genital tuberculosis, particularly uterine tuberculosis, can lead to the development of intrauterine adhesions, contributing to Asherman syndrome.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Uterine Artery Embolization</span></strong>: Uterine artery embolization, typically used to treat uterine fibroids, can cause damage to the endometrium and lead to the formation of intrauterine adhesions.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cesarean Section</span></strong>: Though less common, Asherman syndrome can occur post-cesarean section if there is endometrial damage during the surgery, leading to scar formation.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. E.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervical Biopsy</span></strong>: A cervical biopsy is less likely to cause intrauterine scarring compared to the procedures listed in the other options.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The most comprehensive and accurate answer for the causes of Asherman syndrome in the given options would be <strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">B. A, B, C, D</span></strong>, which encompasses curettage, tuberculosis, uterine artery embolization, and cesarean section.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman syndrome is typically caused by intrauterine trauma or surgery (like curettage or uterine artery embolization), certain infections (like genital tuberculosis), and less commonly by cesarean sections. Understanding these causes is essential for preventing and managing Asherman syndrome, which can lead to secondary amenorrhea and infertility</span></span></span></p>\r\n\r\n<p style=\"margin-left:68px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Asherman syndrome is intrauterine adhesions or synechiae</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">They arise due to</span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Surgical trauma to the uterus which may be seen following</span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dilatation and curettage (esp sharp curettage)</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cesarean section</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Myomectomy where the endometrial cavity is involved</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Metroplasty</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Trans-cervical resection of the endometrium</span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine artery embolization</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Endometrial ablative procedures </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intra-uterine infections like tuberculosis and schistosomiasis</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">But the classical history is usually after a D &amp; C, the patient develops amenorrhoea</span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Symptoms:</span></span>\r\n\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hypomenorrhea</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Secondary amenorrhoea </span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Secondary infertility</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Diagnosis</span></span>\r\n\t<ul style=\"list-style-type:disc\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">On ultrasound:</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">On HSG</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Intra-uterine filling defects are seen giving a moth-eaten appearance</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hysteroscopy</span></span>\r\n\t\t<ul>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#3d3d3d\">Gold standard for diagnosis</span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#3d3d3d\">Treatment:</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:#3d3d3d\">Hysteroscopic adhesiolysis</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\">Post procedure:</span></span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\">&nbsp;To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</span></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"color:black\">Another hysteroscopy or HSG is typically performed at 3 months following the initial resection. </span></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:#3d3d3d\">Ref: Page 1080, William&rsquo;s gynecology, 3<sup>rd</sup> edition</span></span></span></strong></p>",
      "correct_choice_id": 48353,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12099,
      "choices": [
        {
          "id": 48360,
          "text": "<p><span style=\"font-size:12pt;\">PCOS</span></p>"
        },
        {
          "id": 48361,
          "text": "<p><span style=\"font-size:12pt;\">Asherman syndrome</span></p>"
        },
        {
          "id": 48362,
          "text": "<p><span style=\"font-size:12pt;\">Cervical stenosis</span></p>"
        },
        {
          "id": 48363,
          "text": "<p><span style=\"font-size:12pt;\">Gonadal dysgenesis</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 30-year-old female presents to OPD with secondary amenorrhea for 2 years. She has 2 living issues and has undergone two surgical abortions in the past Her BMI is 30 kg/m2. She has no withdrawal bleeding after progesterone or after estrogen and progesterone. The likely cause is:</span></p>",
      "unique_key": "Q4647856",
      "question_audio": null,
      "question_video": null,
      "map_id": 18812,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans. B. Asherman syndrome</strong></span></p><p style=\"margin-left:48px;text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Let us look at the other options:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. A.</strong>&nbsp;<strong>Polycystic Ovary Syndrome (PCOS)</strong>: PCOS is characterized by irregular menstrual cycles, signs of hyperandrogenism (such as hirsutism or acne), and polycystic ovaries on ultrasound. However, women with PCOS typically have some bleeding in response to progesterone due to built-up endometrial lining, making this answer less likely</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. C.</strong>&nbsp;<strong>Cervical Stenosis</strong>: Cervical stenosis refers to the narrowing of the cervical canal. It can cause amenorrhea by physically blocking the passage of menstrual blood. However, in cervical stenosis, the endometrium typically responds to hormonal stimulation and there may be some evidence of trapped blood or hematometra on imaging, distinguishing it from Asherman syndrome.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option. D.</strong>&nbsp;<strong>Gonadal Dysgenesis</strong>: Gonadal dysgenesis, such as Turner syndrome or Swyer syndrome, typically presents with primary amenorrhea and underdeveloped secondary sexual characteristics, not secondary amenorrhea.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Asherman syndrome, characterized by the formation of intrauterine adhesions or scars, typically presents with secondary amenorrhea and a lack of withdrawal bleeding after hormonal challenges. It is often a result of uterine surgery or trauma.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>About Asherman Syndrome:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">The diagnosis of Asherman syndrome is based primarily on a high index of suspicion, based on history. In women whose history suggests this possibility, scant or no withdrawal bleeding after sequential treatment with exogenous estrogen and progestin reflects end-organ endometrial failure and corroborates the clinical suspicion.</span></p></li><li><span style=\"font-size:12pt;\">Asherman syndrome is intra uterine adhesions.</span></li><li><span style=\"font-size:12pt;\">They arise due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Surgical trauma to the uterus which may be seen following</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Dilatation and curettage (esp sharp curettage)</span></li><li><span style=\"font-size:12pt;\">Cesarean section</span></li><li><span style=\"font-size:12pt;\">Myomectomy where the endometrial cavity is involved</span></li><li><span style=\"font-size:12pt;\">Metroplasty</span></li><li><span style=\"font-size:12pt;\">Trans-cervical resection of the endometrium</span></li></ul></li><li><span style=\"font-size:12pt;\">Uterine artery embolization</span></li><li><span style=\"font-size:12pt;\">Endometrial ablative procedures</span></li><li><span style=\"font-size:12pt;\">Intra-uterine infections like tuberculosis and schistosomiasis</span></li></ul></li><li><span style=\"font-size:12pt;\">Symptoms:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\">Hypomenorrhea</span></li><li><span style=\"font-size:12pt;\">Secondary amenorrhoea</span></li><li><span style=\"font-size:12pt;\">Secondary infertility</span></li></ul></li><li><span style=\"font-size:12pt;\">Diagnosis</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12pt;\">On ultrasound</span></li></ul></li><li><span style=\"font-size:12pt;\">Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</span></li><li><span style=\"font-size:12pt;\">On HSG</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Intra-uterine filling defects are seen giving a moth-eaten appearance</span></li></ul></li><li><span style=\"font-size:12pt;\">Hysteroscopy</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Gold standard for diagnosis</span></li></ul></li><li><span style=\"font-size:12pt;\">Treatment:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Hysteroscopic adhesiolysis</span></li><li><span style=\"font-size:12pt;\">Post procedure:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">&nbsp;To stimulate endometrial proliferation and prevent reformation of adhesions, oral oestrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</span></li><li><span style=\"font-size:12pt;\">Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48361,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12101,
      "choices": [
        {
          "id": 48368,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sheehan syndrome</span></span></p>"
        },
        {
          "id": 48369,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Asherman syndrome</span></span></p>"
        },
        {
          "id": 48370,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Premature ovarian insufficiency</span></span></p>"
        },
        {
          "id": 48371,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Polycystic Ovarian syndrome</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 36-year-old P2L2 woman who has undergone a tubal ligation comes to the OPD with amenorrhea 2 years after her ligation. Her FSH is high. Which of the following is the likely diagnosis: </span></span></p>",
      "unique_key": "Q1917737",
      "question_audio": null,
      "question_video": null,
      "map_id": 18813,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C. Premature ovarian insufficiency</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Premature ovarian failure/ or premature ovarian insufficiency is hypergonadotropic hypogonadism and amenorrhea occurring before the age of 40 years. </span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sheehan syndrome and Asherman syndrome will not have raised FSH</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">PCOS will have reversed LH:FSH ratio, have other pointers for diagnosis of PCOS (like the hyperandrogenism or ultrasound morphology suggestive of PCOS)</span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan Syndrome</span></strong>: Sheehan syndrome is caused by pituitary gland damage due to severe blood loss and hypovolemic shock during or after childbirth. It typically presents with low levels of pituitary hormones, not elevated FSH. This condition would cause hypogonadotropic hypogonadism.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Asherman Syndrome</span></strong>: Asherman syndrome is characterized by intrauterine adhesions or scarring and is often a result of uterine surgery. While it can cause amenorrhea, it does not typically result in elevated FSH levels, as the issue is structural rather than ovarian.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polycystic Ovarian Syndrome (PCOS)</span></strong>: PCOS is characterized by irregular menstrual cycles, signs of hyperandrogenism, and polycystic ovaries. PCOS typically involves normal or low FSH levels and does not usually lead to primary ovarian failure.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Premature ovarian insufficiency (POI) is characterized by the loss of normal ovarian function before the age of 40, presenting as amenorrhea with elevated FSH levels, indicative of hypergonadotropic hypogonadism. It is important to consider POI in women under 40 presenting with amenorrhea and high FSH levels, as it has implications for fertility and overall health</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></strong></span></span></p>",
      "correct_choice_id": 48370,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12102,
      "choices": [
        {
          "id": 48372,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">OCP</span></span></p>"
        },
        {
          "id": 48373,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cabergoline</span></span></p>"
        },
        {
          "id": 48374,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dexamethasone</span></span></p>"
        },
        {
          "id": 48375,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oxytocin</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old woman presents to OPD with complaint of secondary amenorrhea. On examination, there is galactorrhoea, and her prolactin levels are high. Urine pregnancy test is negative. Which of the following is treatment of choice for her: </span></span></span></p>",
      "unique_key": "Q4689067",
      "question_audio": null,
      "question_video": null,
      "map_id": 18814,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B. Cabergoline</strong></span></span></p>\r\n\r\n<p style=\"margin-left:48px; text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is a scenario of hyperprolactinemia which commonly presents as galactorrhoea and oligomenorrhoea (Delayed cycles)</span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dopamine agonists are the first line treatment for hyperprolactinemia. Bromocriptine and cabergoline are first line treatments. </span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at the other options:</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oral Contraceptive Pills (OCP)</span></strong>: OCPs are used to regulate menstrual cycles and provide contraception</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></strong>: is a steroid used in the treatment of various conditions, including some endocrine disorders, but it is not a first-line treatment for hyperprolactinemia.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oxytocin</span></strong>: Oxytocin is a hormone that stimulates uterine contractions and milk ejection in lactation</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The treatment of choice for hyperprolactinemia, which often presents with galactorrhoea and secondary amenorrhea, is dopamine agonists such as cabergoline or bromocriptine. These medications effectively lower prolactin levels, which can help restore normal menstrual function and resolve galactorrhoea</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;&nbsp;</span></strong><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Speroff&rsquo;s 9<sup>th</sup> edition chapter 10, amenorrhea</span></strong></span></span></p>",
      "correct_choice_id": 48373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12104,
      "choices": [
        {
          "id": 48380,
          "text": "<p><span style=\"font-size:12pt;\">Asherman syndrome</span></p>"
        },
        {
          "id": 48381,
          "text": "<p><span style=\"font-size:12pt;\">Sheehan syndrome</span></p>"
        },
        {
          "id": 48382,
          "text": "<p><span style=\"font-size:12pt;\">PCOS</span></p>"
        },
        {
          "id": 48383,
          "text": "<p><span style=\"font-size:12pt;\">Primary ovarian insufficiency</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">A 30 y comes to OPD for evaluation of absent periods. The patient had a vaginal delivery 8 months ago and she’s not had her period since delivery. Her postpartum course was complicated by atonic PPH requiring massive blood transfusion. At a visit, 2 months ago, the patient was started on combined OCPs, and she has not had vaginal bleeding. Prior to this pregnancy she had regular monthly cycles. She also has increased fatigue. She is not lactating and is bottle feeding her baby. There is no headache, galactorrhoea, or hot flushes. BMI is 31, vitals are normal. Pelvic examination shows clear vaginal discharge and well rugate vagina. The uterus is small and anteverted. UPT is negative. TSH levels are elevated. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q4036944",
      "question_audio": null,
      "question_video": null,
      "map_id": 18815,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B. Sheehan Syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Etiopathogenesis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">During pregnancy, the <strong>pituitary gland enlarges</strong> due to hyperplasia of lactotrophs.</span></li><li><span style=\"font-size:16px;\">In the setting of <strong>severe blood loss or hypotension</strong> during/after delivery, the <strong>enlarged pituitary is vulnerable to ischemia</strong>.</span></li><li><span style=\"font-size:16px;\">Leads to <strong>necrosis of pituitary tissue</strong>, resulting in <strong>partial or complete hypopituitarism</strong>.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Clinical Features:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Early signs:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Failure to lactate (due to ↓ prolactin)</span></li><li><span style=\"font-size:16px;\">Prolonged amenorrhea or oligomenorrhea</span></li><li><span style=\"font-size:16px;\">Fatigue, hypotension</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Late signs:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Loss of secondary sexual hair (pubic/axillary)</span></li><li><span style=\"font-size:16px;\">Cold intolerance, dry skin (↓ TSH)</span></li><li><span style=\"font-size:16px;\">Hypoglycemia, weight loss (↓ ACTH, cortisol)</span></li><li><span style=\"font-size:16px;\">Infertility</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Diagnosis:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">History of <strong>severe PPH</strong> with failure to resume normal postpartum function</span></li><li><span style=\"font-size:16px;\">Hormonal assays: ↓ levels of <strong>prolactin, ACTH, TSH, LH, FSH, GH</strong></span></li><li><span style=\"font-size:16px;\"><strong>MRI of pituitary</strong> may show an empty sella or hypoplastic gland</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Treatment:</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Lifelong hormone replacement therapy</strong>, including:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\"><strong>Glucocorticoids</strong> (hydrocortisone)</span></li><li><span style=\"font-size:16px;\"><strong>Levothyroxine</strong></span></li><li><span style=\"font-size:16px;\"><strong>Estrogen/progesterone</strong> (if fertility not desired)</span></li><li><span style=\"font-size:16px;\"><strong>Gonadotropins</strong> (if fertility desired)</span></li></ul></li></ul><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Let us look at the other options:</span></p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A.</strong> <strong>Asherman syndrome</strong>: Asherman syndrom<strong>e</strong> is a condition characterized by intrauterine adhesions or synechiae, often resulting from trauma to the endometrium, typically after dilation and curettage. It leads to menstrual abnormalities (amenorrhea or hypomenorrhea), infertility, and recurrent pregnancy loss. Diagnosis is confirmed by hysteroscopy, and treatment involves surgical adhesiolysis.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. C.</strong>&nbsp;<strong>Polycystic Ovary Syndrome (PCOS)</strong>: PCOS is an endocrine disorder characterized by irregular menstrual cycles, signs of hyperandrogenism, and polycystic ovaries. While the patient has an elevated BMI, a common feature in PCOS, the absence of her periods following a complicated postpartum course and the absence of typical PCOS symptoms make this diagnosis less likely.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Option. D.</strong>&nbsp;<strong>Primary Ovarian Insufficiency</strong>: Primary ovarian insufficiency, also known as premature ovarian failure, involves early depletion of ovarian follicles and usually presents with elevated FSH levels, which is not the case here.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\"><strong>Educational Objective</strong>:&nbsp;</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:16px;\">Asherman syndrome, characterized by intrauterine adhesions or scarring typically following uterine surgery or trauma, is the most likely cause of secondary amenorrhea in a patient with a history of postpartum hemorrhage and D&amp;C. The diagnosis is supported by the absence of menstrual bleeding even with hormonal stimulation and a history suggestive of intrauterine injury.</span></p><p style=\"text-align:justify;\">&nbsp;</p><ul><li><span style=\"font-size:16px;\">Asherman syndrome is intra uterine adhesions, they arise due to:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Surgical trauma to the uterus which may be seen following</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:16px;\">Dilatation and curettage (esp. sharp curettage)</span></li><li><span style=\"font-size:16px;\">Cesarean section</span></li><li><span style=\"font-size:16px;\">Myomectomy where the endometrial cavity is involved</span></li><li><span style=\"font-size:16px;\">Metroplasty</span></li><li><span style=\"font-size:16px;\">Trans-cervical resection of the endometrium</span></li></ul></li><li><span style=\"font-size:16px;\">Uterine artery embolization</span></li><li><span style=\"font-size:16px;\">Endometrial ablative procedures</span></li><li><span style=\"font-size:16px;\">Intra-uterine infections like tuberculosis and schistosomiasis</span></li></ul></li><li><span style=\"font-size:16px;\">Symptoms:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Hypomenorrhea</span></li><li><span style=\"font-size:16px;\">Secondary amenorrhoea</span></li><li><span style=\"font-size:16px;\">Secondary infertility</span></li></ul></li><li><span style=\"font-size:16px;\">Diagnosis</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">On ultrasound</span></li></ul></li><li><span style=\"font-size:16px;\">Uterine cavity appears irregular/ interrupted; punctate echogenic foci in the endometrium/ indistinct endo-myometrial junction/ endometrial fluid: commonly loculated appearing as small focal cystic areas within the endometrium</span></li><li><span style=\"font-size:16px;\">On HSG</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Intra-uterine filling defects are seen giving a moth-eaten appearance</span></li></ul></li><li><span style=\"font-size:16px;\">Hysteroscopy</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Gold standard for diagnosis</span></li></ul></li><li><span style=\"font-size:16px;\">Treatment:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:16px;\">Hysteroscopic adhesiolysis</span></li><li><span style=\"font-size:16px;\">Post procedure:</span><ul style=\"list-style-type:square;\"><li><span style=\"font-size:16px;\">&nbsp;To stimulate endometrial proliferation and prevent reformation of adhesions, oral estrogen administration has proved effective. A cooper containing intra-uterine device can also be inserted to prevent reformation of adhesions</span></li><li><span style=\"font-size:16px;\">Another hysteroscopy or HSG is typically performed at 3 months following the initial resection.</span></li></ul></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref: Speroff’s 9<sup>th</sup> edition chapter 10, amenorrhea</strong></span></p>",
      "correct_choice_id": 48381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12106,
      "choices": [
        {
          "id": 48388,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated luteinizing hormone (LH) level</span></span></p>"
        },
        {
          "id": 48389,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated gonadotropin-releasing hormone (GnRH) level</span></span></p>"
        },
        {
          "id": 48390,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated leptin level</span></span></p>"
        },
        {
          "id": 48391,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Elevated neuropeptide Y level</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An 18-year-old with previously regular menses, presents with amenorrhea. She is also diagnosed with anorexia nervosa. Which of the following is likely to be seen in this patient?</span></span></p>",
      "unique_key": "Q8081570",
      "question_audio": null,
      "question_video": null,
      "map_id": 18816,
      "difficulty_level": "difficult",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D. Elevated neuropeptide Y level</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In anorexia nervosa, there is Hypogonadotrophic hypogonadism</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The FSH, LH levels are reduced and so are the estrogen levels</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Various biologic actors have been implicated in eating disorder development</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Abnormalities in neuropeptides, neurotransmitters, and hypothalamic-pituitary-adrenal and hypothalamic-pituitary-gonadal axes are reported </span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients with anorexia nervosa have been found to have low circulating leptin levels</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It has been hypothesized that a decrease in leptin production due to weight loss could secondarily stimulate neuropeptide Y, which is known to stimulate hunger and alter GnRH pulsatility.</span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Let us look at each option </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\"><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option. A.</strong>&nbsp;<strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Luteinizing Hormone (LH) Level</span></strong>: Incorrect. In anorexia nervosa, there is typically hypogonadotropic hypogonadism, characterized by low levels of gonadotropins, including LH. This is due to the body&#39;s response to starvation and undernutrition.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Gonadotropin-Releasing Hormone (GnRH) Level</span></strong>: Incorrect. GnRH levels are often reduced in anorexia </span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Leptin Level</span></strong>: Incorrect. Leptin, a hormone produced by adipose tissue, is typically low in anorexia nervosa due to the loss of body fat. Low leptin levels are associated with reduced energy intake and weight loss.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Elevated Neuropeptide Y Level</span></strong>: Correct. Neuropeptide Y is involved in the regulation of appetite and is known to stimulate hunger. In anorexia nervosa, the decrease in leptin due to weight loss can lead to an increase in neuropeptide Y as a compensatory mechanism to stimulate appetite. Additionally, neuropeptide Y can alter GnRH pulsatility, contributing to menstrual irregularities.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In anorexia nervosa, there is typically hypogonadotropic hypogonadism with reduced levels of LH, FSH, and estrogen. Low circulating leptin levels due to weight loss can stimulate neuropeptide Y, which affects appetite regulation and GnRH pulsatility. This hormonal dysregulation contributes to the development of amenorrhea in patients with anorexia nervosa.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 404, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></p>",
      "correct_choice_id": 48391,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12109,
      "choices": [
        {
          "id": 48400,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Patients typically present with amenorrhea. </span></span></p>"
        },
        {
          "id": 48401,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is the most common cause of chronic anovulation. </span></span></p>"
        },
        {
          "id": 48402,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is characterized by hypogonadotropic hypogonadism.</span></span></p>"
        },
        {
          "id": 48403,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">It is characterized by persistently elevated follicle stimulating hormone (FSH) and oestradiol levels</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements is true regarding polycystic ovarian syndrome?</span></span></p>",
      "unique_key": "Q1043930",
      "question_audio": null,
      "question_video": null,
      "map_id": 18817,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B. It is the most common cause of chronic anovulation. </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PCOS</span></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This is syndrome is by far the most common cause of chronic anovulation</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Women with PCOS have different menstrual patterns</span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Amenorrhoea due to anovulation</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Heavy menstrual bleeding and intermenstrual bleeding can result from unopposed estrogen stimulation of the endometrium</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In PCOS</span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">LH &gt; FSH</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Oestradiol levels are usually normal</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"margin-left:96px; text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Let&#39;s evaluate each statement regarding polycystic ovarian syndrome (PCOS):</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. A.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Patients typically present with amenorrhea</span></strong>: While amenorrhea can occur in PCOS, it&#39;s more common for patients to present with irregular menstrual cycles or oligomenorrhea rather than complete absence of menstruation. </span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is the most common cause of chronic anovulation</span></strong>: Correct. This chronic anovulation contributes to irregular menstrual cycles and infertility, both hallmark symptoms of PCOS.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by hypogonadotropic hypogonadism</span></strong>: This is incorrect. PCOS is actually characterized by hyperandrogenism (excess male hormones) and is not typically associated with hypogonadotropic hypogonadism. In fact, women with PCOS often have normal or slightly elevated levels of gonadotropins like LH.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option. D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is characterized by persistently elevated follicle stimulating hormone (FSH) and oestradiol levels</span></strong>: This statement is not accurate for PCOS. In PCOS, FSH levels are usually normal or slightly lower, not persistently elevated. The hormonal hallmark of PCOS is an elevated LH to FSH ratio, along with elevated levels of androgens.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">Educational Objective</span></span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><span style=\"color:black\">: Polycystic ovarian syndrome (PCOS) is the most common cause of chronic anovulation and is characterized by symptoms such as irregular menstrual cycles, hyperandrogenism, and polycystic ovaries. Understanding PCOS&#39;s clinical presentation and hormonal profile is essential for diagnosis and management.</span></span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 406, Williams Gynecology 3<sup>rd</sup> edition</span></span></strong></p>",
      "correct_choice_id": 48401,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}